Free Trial

Myriad Genetics (MYGN) SEC Filings & 10K Form

Myriad Genetics logo
$7.56 +0.43 (+6.03%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$7.56 0.00 (0.00%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Myriad Genetics SEC Filings

DateFilerForm TypeView
05/01/2025
3:24 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:27 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
4:32 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:06 PM
Myriad Genetics (Filer)
Form DEF 14A
04/09/2025
3:08 PM
Myriad Genetics (Filer)
Form DEFA14A
03/25/2025
3:16 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:16 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:16 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:17 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:17 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:17 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:19 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:19 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:19 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:19 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:31 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:31 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:31 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:31 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:31 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:32 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:36 PM
Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:05 PM
Myriad Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
3:21 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:32 AM
Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
Form SCHEDULE 13G/A
02/10/2025
9:25 AM
Myriad Genetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/30/2025
3:23 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
7:39 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:19 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:36 PM
Davis Mark Steven (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:51 PM
Davis Mark Steven (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/02/2024
3:17 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
3:42 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:18 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/11/2024
4:23 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
9:35 AM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:31 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:33 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:36 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
5:11 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
09/23/2024
3:17 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:21 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
1:30 PM
Ancona Margaret (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:09 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
2:26 PM
Muzzey Dale (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
9:05 AM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
4:48 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
1:52 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
6:51 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:38 PM
Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:43 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
3:33 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
9:11 AM
Myriad Genetics (Subject)
Reitan Colleen F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:48 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:16 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:38 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
1:46 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
3:27 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
7:22 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/04/2024
4:57 PM
Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
9:32 AM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:48 PM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
4:48 PM
Myriad Genetics (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:49 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:24 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
11:14 AM
Myriad Genetics (Subject)
Newcomer Lee Nisley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
7:14 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MYGN) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners